Logo Logo
Mobile Logo
book now
Logo&nsbp;
  • Home
  • Agenda
    • View Web-AgendaSee all the exciting sessions we have in store for you.
    • Download Agenda
    • BOOK NOW
  • Speakers
    • PanelFind out which experts will share their insights and use cases at Auto.AI USA
    • Become a speaker
    • BOOK NOW
  • Partners
    • Co-Located Event1 Sponsorship – 4 Targeted Conferences
    • Business PartnersNetwork with our partner community and discover their cutting-edge products & services
    • Why Partner?Connect with the right people in a space designed to optimize your relationship-building and deal-making
    • Matchmaking & One2OnesMeet the right decision makers based on your interest
    • Get Partner Packages
    • Current participants list
    • Past event attendeelist
  • Who & Why?
    • The Event at a glanceWhat can you expect as an attendee at Pharma Maintenance Reloaded
    • AttendeesYou will meet decision makers from the industries that matter to you – digital or live!
    • 10 reasons to attendWhy you should join
    • Testimonials
    • Current participants list
    • Past event attendeelist
  • Event Info
    • Travel & LocationOnsite Location
    • Evening EventsIcebreaker + Networking Dinner
    • Info for ModeratorsFind out more about how to hold your interactive session
    • Co-Located Events1 Sponsorship – 4 Conferences
    • ContactGET IN TOUCH - We are here for you!
  • Content Hub
    • Video Case StudiesExplore Our Video Case Studies! Inspirational success stories, technologies, and solutions from our speakers!
    • InterviewsVideo Interviews with Our Speakers! Exciting conversations, insights, and expertise on the latest trends & technologies.
    • Whitepapers & ReportsTrend Reports & Whitepapers! In-depth analyses, industry insights, and expert perspectives on key trends and developments.
    • BOOK NOW
  • EXHIBIT NOW
  • BOOK NOW
CO-LOCATED EVENTS

Speaker

Timo Flessner

SVP, Manufacturing API & Medical Devices Lead, Bayer AG

Timo Flessner, Senior Vice President, has broad operational and senior management experience in pharmaceutical R&D, manufacturing & Product Supply.

Since June 2024 he takes the role as the Manufacturing API & Medical Devices Lead at Bayer Pharma Product Supply. The portfolio in API and MD manufacturing, is rich in diversity and complexity, spans across 11 global sites. MD adds to his former responsibility and brings new challenges as change, fostering collaboration, and setting new benchmarks in the supply of active pharmaceutical ingredients and a diverse portfolio of medical devices.

Since October 2020 he took responsibility for the Global API (Active Pharmaceutical Ingredient) Product Supply organization. The main focus is on API supply for clinical studies as well as launch & the longer-term commercial life-cycle of a broad product portfolio.

In the previous role he was the Site Manager for the Pharma site in Wuppertal - which is the founding place of Bayer & includes Pharma R&D and API Product Supply operations. Before he was the Site Manager for the Bayer Supply Center Bergkamen as well as the Supply organization in Berlin-Charlottenburg. Before moving into the site manager responsibilities he was heading Global Chemical Development with a focus on the development of chemical & technological processes to ensure API supply concepts & security for preclinical, clinical studies, submission & launch.

From 2000-2011 he held various positions of increasing responsibility in Bayer´s / Bayer HealthCare’s Global Drug Discovery (Head of chemistry labs, Chief of staff for PH Research and PH R&D, Director & Head of a Medicinal Chemistry Department).

In addition to his responsibilities at Bayer he is a non-executive advisor for start-up companies and a lecturer at the University of Hannover since 2015 (Making Drugs: Research, Development & Industrialization of API). His strong ambition for sustainability drove him into a supporter role for the Circular Valley initiative. In an additional assignment he is a member of the board of the GDCh (2016-2024). Apart from the professional level he is active in voluntary work, e.g. in an initiative in Wuppertal that supports the city & people in need. He is married and a proud father of two sons.

He holds a PhD in Chemistry. He was educated at the Universities of Oldenburg, Hannover and Paris-Sud (Diploma in Chemistry). He received his PhD with Prof. E. Winterfeldt in 1999 from the University of Hannover. He worked as a Postdoc in the group of Prof. C.-H. Wong at the Scripps Research Institute in San Diego.

Join Timo Flessner
Book Now!

Sessions

Bayer's Dynamic Shared Ownership (DSO) Operating Model — A Catalyst for Operational Excellence in Pharma Manufacturing

Case Study

Monday, September 22

08:35 am - 09:00 am

Live in Berlin

Less Details

As pharmaceutical manufacturers navigate increasing cost pressures and supply chain complexities, Dynamic Shared Ownership (DSO) emerges as a transformative approach to drive operational excellence. By shifting responsibility for profit and loss, DSO fosters a culture of accountability, continuous improvement, and lean manufacturing. This session will explore how Bayer’s DSO-driven operating model enhances asset ownership, optimizes supply chain performance, and enables more efficient ways of working. Attendees will gain insights into the practical application of DSO and its role in reshaping pharma manufacturing for greater agility and cost-effectiveness. In this session you will learn how to …

  • Leverage DSO to enhance operational excellence and streamline pharma manufacturing processes.
  • Navigate supply chain challenges with a product-focused, cost-conscious approach.
  • Understand the transfer of responsibility for profit and loss and its impact on efficiency.
  • Implement lean manufacturing principles through a DSO-driven model.
  • Explore Bayer’s operating model and its role in transforming asset ownership and continuous improvement.
Presentation

The Future of Pharma Manufacturing — Balancing Innovation, Resilience, and Operational Excellence

Panel Discussion

Monday, September 22

06:10 pm - 06:55 pm

Live in Berlin

Less Details

As pharmaceutical manufacturers face rising cost pressures, supply chain disruptions, and increasing demands for efficiency, the industry must rethink its approach to operational excellence. A holistic strategy—one that integrates innovative business models, digitalization, and resilient supply chains—is essential to navigating these challenges. From supply chain resilience in an era of geopolitical uncertainty to the role of new ownership models like Dynamic Shared Ownership (DSO), panelists will discuss how companies can optimize efficiency while remaining agile and competitive. In this session, you will learn more about:

  • Redefining Operational Excellence: Exploring new strategies to drive efficiency, cost-effectiveness, and continuous improvement in pharma manufacturing.
  • Supply Chain Resilience in a Volatile World: Addressing geopolitical tensions, rising costs, and how to build a future-proof supply chain.
  • The Role of Dynamic Shared Ownership (DSO): Understanding its impact on asset management, accountability, and lean manufacturing.
  • Digitalization and AI in Manufacturing: Leveraging technology to optimize decision-making and streamline production.
  • New Ways of Working: How evolving workforce models and collaboration approaches are reshaping the industry.
Panel Discussion

Company

Bayer AG

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world.
Get Agenda
Book Now
Colocated with
Pharma Maintenance Europe 2025 is part of the Smart Manufacturing & Industry 4.0 Event Series. You can find more events here.
Date
September 22 – 23, 2025
Location
Maritim proArte Hotel
Friedrichstraße 151, Dorotheenstraße 65
10117 Berlin
Phone
+49 (0)30 52 10 70 3 0
eMail
  • To sponsor
  • To speak
  • Media partnerships
  • General inquiries
  • Imprint
  • Terms & Conditions
  • Privacy
© we.CONECT Global Leaders GmbH